Troxacitabine in patients with refractory leukemia.
Karrison
Theodore
T
Ratain
Mark
M
D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D017322:Clinical Trials, Phase II as Topic; D003596:Cytosine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004148:Dioxolanes / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D004148:Dioxolanes; C074908:troxacitabine; D003596:Cytosine